Skip to Content
 
Center for International Blood and Marrow Transplant Research

GV26-02

Main Content

Real-World Outcomes of Post-Transplantation Cyclophosphamide Versus Calcineurin inhibitor-based Graft-Versus-Host Disease Prophylaxis for Second Allogeneic Hematopoietic Cell Transplantation

Study #: GV26-02

Study Status: Protocol Development